Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Emergent BioSolutions Inc.

EBS•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$10.90
$-0.09(-0.82%)
U.S. Market is Open • 14:21

Emergent BioSolutions Inc. (EBS) Stock Overview

Explore Emergent BioSolutions Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap582.6M
P/E Ratio7.67
EPS (TTM)$1.32
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$7.96
3 Months$7.43
1 Year Target$13.92

EBS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Emergent BioSolutions Inc. (EBS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.67 and a market capitalization of 582.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.64%
5-Day Change
-0.73%
1-Month Change
-1.62%
3-Month Change
20.26%
6-Month Change
18.05%
Year-to-Date (YTD) Change
-12.71%
1-Year Change
39.29%
3-Year Change
-21.50%
5-Year Change
-88.83%
All-Time (Max) Change
-6.67%

Contact Information

https://www.emergentbiosolutions.com
240 631 3200
400 Professional Drive, Gaithersburg, MD, 20879

Company Facts

9,000 Employees
IPO DateNov 15, 2006
CountryUS
Actively Trading

Frequently Asked Questions